Rochester undergraduates developed a 3D-bioprinting system to replicate chemicals found in plants, including those endangered by climate change.
Imagine a world without plants. Although this extreme scenario has not become a reality, Earth is facing a concerning trend—the rapid depletion of potential plant-derived drugs. Globally, tens of thousands of flowering plant species play vital roles in medicinal applications, but many of the pharmaceuticals dominating the United States market heavily rely on imported raw plant materials that require very particular climate conditions for optimal growth. The threat to many plant species is intensified by factors such as climate change, invasive pests and diseases, and farming practices struggling to meet the large demand for end products.
To address these problems, a team of 10 University of Rochester undergraduate students pioneered new technologies to more efficiently replicate useful chemicals found in plants, including those endangered by Earth’s changing climate. Calling themselves “Team RoSynth,” the students created an affordable 3D-printing system for optimizing production of in-demand, plant-derived drugs and pharmaceuticals.
In November, the team entered their research in the 2023 International Genetically Engineered Machine (iGEM) competition, an event in which student-led teams from around the globe compete to solve real-world problems using synthetic biology. Synthetic biology takes advantage of engineering to build biological parts inspired by nature. The Rochester team’s project was nominated for the Best Biomanufacturing Project and Best Hardware and was awarded a gold medal, making them the third most recognized team in the United States. The team competed against 402 teams from six continents.
“Team RoSynth’s technology has huge potential to push forward the entire field of synthetic biology, allowing for straightforward, accessible production of new engineered living materials,” says Anne S. Meyer, an associate professor in the Department of Biology and one of the advisors for Rochester’s iGEM team.
An ‘ingenious’ method of bioprinting hydrogels
Team RoSynth designed their 3D bioprinter to print hydrogels—jelly-like substances made of water and polymers that can hold and release biological molecules. The Rochester team’s system is unique because it prints genetically engineered bacteria and genetically engineered yeast in adjacent hydrogels, which are then submerged in a liquid nutrient broth. The complex work of making the final product chemical is divided among the two different types of microbes, making the process go more easily and quickly.
A key innovation lies in the fact that the yeast and the bacteria need to grow separately to prevent one microbe from growing faster and causing the slower-growing microbe to die off; however, the two microbes also need to be able to exchange molecules to build up the final product chemical.
“A typical bioprinter will cost over $10,000, but we engineered one under $500.” —Allie Tay ’25
“To solve this tricky problem, the students devised an ingenious solution,” Meyer says. “The yeast and the bacteria were 3D bioprinted in hydrogels, so the microbes were kept separate from each other, but the molecules they produced could exchange freely.”
The approach results in the synthetic creation of plant-based chemicals, without the need for actual plants.
As a test case, the team biochemically synthesized rosmarinic acid (RA). RA is typically extracted from plants such as rosemary, sage, and fern. It is used as a flavoring and in cosmetics and has also been shown to have antioxidant and anti-inflammatory properties. While rosmarinic acid is not itself endangered, it was an ideal extract to test.
“Rosmarinic acid is a valued plant compound but was not toxic or hazardous to the students to produce,” Meyer says. “Plus, the pathway to make it is pretty complex, consisting of a large number of enzymes that act sequentially.”
A response to climate change
The team, which is completely student led with several faculty members on hand as advisors, began brainstorming project ideas at the beginning of 2023. Inspired by the COVID-19 pandemic, climate change, and Rochester’s location near agricultural hubs in New York, the team prioritized addressing climate impacts on supplies of plant-based chemicals.
“Since we are located in Rochester, which is adjacent to the Finger Lakes region, a major agricultural area in New York State, we thought about how the impact of climate change will lead to decreasing crop yields over the coming years and impact local supplies of plants and plant-based compounds,” says Catherine Xie, ’25, a molecular genetics major.
Adds Medha Pan ’24, also a molecular genetics major: “Our iGEM team was focusing on the climate crisis and agricultural shortages that we have been facing, especially in the COVID era. We have seen firsthand the importance of having accessible and reliable medication.”
“Since we are located in Rochester, which is adjacent to the Finger Lakes region, a major agricultural area in New York State, we thought about how the impact of climate change will lead to decreasing crop yields over the coming years and impact local supplies of plants and plant-based compounds,””
Examples of specific drugs that might benefit from the methods and technologies developed by Team RoSynth include aspirin, which is derived from willow tree bark, and the cancer drug taxol, developed by species of yew trees that have been identified as needing protection.
An affordable bioprinter
Part of the team’s mission was to a create an affordable bioprinter with an open-source design to empower others to explore synthetically creating plant-based chemicals.
“A typical bioprinter will cost over $10,000, but we engineered one under $500,” says Allie Tay ’25, a biomedical engineering major. “We wanted to have a 3D bioprinter that would be accessible for labs to do this proof of concept with whichever molecules they choose.”
The project is such that other scientists can change the genes and the engineered pathways in the bacteria and yeast to produce virtually any plant-based chemical. The design of the bioprinter itself is available on the team’s Wiki page and includes a guide on how to build and use the printer so others can create and adapt the technology for a variety of uses.
Blending nature with cutting-edge technology, the team proved that undergraduates can lead groundbreaking projects in record time.
“Projects like these usually take years for PhD or grad students to develop,” Tay says, “and the fact that we’re undergrads doing this and we were given from February to November—I think that’s a pretty big undertaking.”
Original Article: Printing plant-based pharmaceuticals—without plants
More from: University of Rochester
The Latest Updates from Bing News
Go deeper with Bing News on:
Synthetic plant-based chemicals
- A Giant Plastics Chemical Recycling Plant Planned for Pennsylvania Died After Two Years. What Happened?
Encina said it’s reviewing new, bigger locations overseas, and chasing growing demand. Critics see multiple fatal flaws with its plans.
- The 25 Best Natural Face Washes in 2024
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. Natural and clean skincare is all the rage these days. No one wants to put ...
- Bioplastics as toxic as regular plastics; both need regulation, say researchers
As negotiators meet this week for the fourth round of global plastics treaty talks, scientists warn that both plant-based and petroleum-based plastics are toxic, with both needing tough regulation to ...
- Research seeks solution to PFAS chemicals in waste
Texas A&M AgriLife Research scientists are looking for a better way to remove or degrade stubborn pollutants, also called forever chemicals, from waste before they impact human and animal health.
- A complete guide to fashionable and durable sustainable leather alternatives
We asked experts about the best sustainable leather alternatives, the environmental impact of vegan leather in fashion and how to avoid greenwashing your closet.
Go deeper with Bing News on:
Plant-derived drugs
- Should You Use Rapeseed Oil? Everything You Need to Know
Rapeseed is a plant that produces oil, which people use for cooking and industrial processes. Here’s what you need to know about its health benefits.
- Crude Prices Finish Higher on Middle East Tensions
WTI crude oil (CLM24) on Friday closed up +0.28 (+0.34%), and May RBOB gasoline (RBK24) closed up +1.07 (+0.39%). Crude and gasoline prices posted moderate gains on Friday. Middle East tensions are ...
- Cannabis legalization has led to a boom in potent forms of the drug that present new hazards for adolescents
The THC concentration of products sold in stores generally ranges from 40% to 70%. That's way higher than the levels in the illegal forms seized by the DEA in the 1990s.
- Completely New Use Discovered – This Traditional Herb Has Remarkable Nerve Regenerative Properties
Blessed thistle (Cnicus benedictus), a member of the Asteraceae family, thrives in our climate. This plant has been utilized for centuries as a medicinal herb, often consumed as an extract or tea to ...
- Opioid Crisis: McKinsey's Reckoning Amidst DOJ Investigation
The opioid epidemic has wreaked havoc across the United States, leaving a trail of addiction, suffering, and loss. Amidst this crisis, McKinsey & Company, a renowned global consulting firm, finds ...